Home
Categories
Cart
Wishlist
Menu

Best Brands

  • currency-country-active
    Delivery to, Saudi Arabia

    • Product share

    Betmiga 50 mg 30 Tablet

    SKU: Z.49723.17284214946711352
    |
    0 Reviews
    Tax-free
    Weight:  kg

    SAR 183.90

    +  

    Earn loyalty points with this purchase

    Rewards  

    Description

    Relaxes the muscles in the bladder, which helps to reduce urinary frequency and urgency.

     

    This product is out of stock

    Notify me when product is available

    This product is out of stock

    Notify me when product is available

    Product Description

    Product Description:

    • Betmiga is a medicine containing the active substance mirabegron.
    • It is available as prolonged-release tablets (25 mg, 50 mg).
    • Prolonged-release’ means that mirabegron is released slowly from the tablet over a few hours.
    • etmiga is used in adults with overactive bladder syndrome.

    It is used to treat certain symptoms of the condition:

    • urgency (sudden urge to urinate), increased urinary frequency (the need to urinate frequently) and urge incontinence (involuntary leakage of urine from the bladder when a sudden strong need to urinate is felt).
    • The medicine can only be obtained with a prescription.

    How To use:

    • The recommended dose of Betmiga is 50 mg once a day.
    • In patients who have reduced kidney or liver function the doctor may need to prescribe a lower dose or avoid the use of Betmiga, especially in patients taking certain other medicines.

    Warnings And Precautions:

    Do not take BETMIGA if you have an allergy to:

    • Any medicine containing mirabegron

    Some of the symptoms of an allergic reaction may include:

    • Shortness of breath.
    • Wheezing or difficulty breathing.
    • Swelling of the face, lips, tongue or other parts of the body.
    • Rash, itching or hives on the skin.

    Do not take BETMIGA:

    • if you have very high blood pressure (systolic greater than or equal to 180mmhg and /or diastolic greater than or equal to 110mmhg).
    • If you are not sure whether you should start taking this medicine, talk to your doctor.
    • Before you start to take it
    • Tell your doctor if you have allergies to any other medicines, foods, preservatives or dyes.
    • Tell your doctor if you have or have had any of the following medical conditions:
    • Kidney problems
    • Liver problems
    • High blood pressure
    • Heart disorders, including an irregular heartbeat, an abnormal electrical signal in the heart that can cause an irregular heart rhythm called "prolongation of the QT interval", or if you are taking any medicine known to cause irregular heart rhythm (see 'Taking other medicines')
    • Trouble emptying your bladder or you have a weak urine stream
    • Tell your doctor if you are pregnant or plan to become pregnant or are breast-feeding. Your doctor can discuss with you the risks and benefits involved.

    Ingredients:

    • Betmiga 25 mg prolonged-release tablets
    • Betmiga 50 mg prolonged-release tablets

    Product Description:

    • Betmiga is a medicine containing the active substance mirabegron.
    • It is available as prolonged-release tablets (25 mg, 50 mg).
    • Prolonged-release’ means that mirabegron is released slowly from the tablet over a few hours.
    • etmiga is used in adults with overactive bladder syndrome.

    It is used to treat certain symptoms of the condition:

    • urgency (sudden urge to urinate), increased urinary frequency (the need to urinate frequently) and urge incontinence (involuntary leakage of urine from the bladder when a sudden strong need to urinate is felt).
    • The medicine can only be obtained with a prescription.

    How To use:

    • The recommended dose of Betmiga is 50 mg once a day.
    • In patients who have reduced kidney or liver function the doctor may need to prescribe a lower dose or avoid the use of Betmiga, especially in patients taking certain other medicines.

    Warnings And Precautions:

    Do not take BETMIGA if you have an allergy to:

    • Any medicine containing mirabegron

    Some of the symptoms of an allergic reaction may include:

    • Shortness of breath.
    • Wheezing or difficulty breathing.
    • Swelling of the face, lips, tongue or other parts of the body.
    • Rash, itching or hives on the skin.

    Do not take BETMIGA:

    • if you have very high blood pressure (systolic greater than or equal to 180mmhg and /or diastolic greater than or equal to 110mmhg).
    • If you are not sure whether you should start taking this medicine, talk to your doctor.
    • Before you start to take it
    • Tell your doctor if you have allergies to any other medicines, foods, preservatives or dyes.
    • Tell your doctor if you have or have had any of the following medical conditions:
    • Kidney problems
    • Liver problems
    • High blood pressure
    • Heart disorders, including an irregular heartbeat, an abnormal electrical signal in the heart that can cause an irregular heart rhythm called "prolongation of the QT interval", or if you are taking any medicine known to cause irregular heart rhythm (see 'Taking other medicines')
    • Trouble emptying your bladder or you have a weak urine stream
    • Tell your doctor if you are pregnant or plan to become pregnant or are breast-feeding. Your doctor can discuss with you the risks and benefits involved.

    Ingredients:

    • Betmiga 25 mg prolonged-release tablets
    • Betmiga 50 mg prolonged-release tablets

    About the product

    Product Description:

    • Betmiga is a medicine containing the active substance mirabegron.
    • It is available as prolonged-release tablets (25 mg, 50 mg).
    • Prolonged-release’ means that mirabegron is released slowly from the tablet over a few hours.
    • etmiga is used in adults with overactive bladder syndrome.

    It is used to treat certain symptoms of the condition:

    • urgency (sudden urge to urinate), increased urinary frequency (the need to urinate frequently) and urge incontinence (involuntary leakage of urine from the bladder when a sudden strong need to urinate is felt).
    • The medicine can only be obtained with a prescription.

    How To use:

    • The recommended dose of Betmiga is 50 mg once a day.
    • In patients who have reduced kidney or liver function the doctor may need to prescribe a lower dose or avoid the use of Betmiga, especially in patients taking certain other medicines.

    Warnings And Precautions:

    Do not take BETMIGA if you have an allergy to:

    • Any medicine containing mirabegron

    Some of the symptoms of an allergic reaction may include:

    • Shortness of breath.
    • Wheezing or difficulty breathing.
    • Swelling of the face, lips, tongue or other parts of the body.
    • Rash, itching or hives on the skin.

    Do not take BETMIGA:

    • if you have very high blood pressure (systolic greater than or equal to 180mmhg and /or diastolic greater than or equal to 110mmhg).
    • If you are not sure whether you should start taking this medicine, talk to your doctor.
    • Before you start to take it
    • Tell your doctor if you have allergies to any other medicines, foods, preservatives or dyes.
    • Tell your doctor if you have or have had any of the following medical conditions:
    • Kidney problems
    • Liver problems
    • High blood pressure
    • Heart disorders, including an irregular heartbeat, an abnormal electrical signal in the heart that can cause an irregular heart rhythm called "prolongation of the QT interval", or if you are taking any medicine known to cause irregular heart rhythm (see 'Taking other medicines')
    • Trouble emptying your bladder or you have a weak urine stream
    • Tell your doctor if you are pregnant or plan to become pregnant or are breast-feeding. Your doctor can discuss with you the risks and benefits involved.

    Ingredients:

    • Betmiga 25 mg prolonged-release tablets
    • Betmiga 50 mg prolonged-release tablets

    Total Products

    SAR 183.90

    Multiple payment methods

    and safe

    apple_pay
    mada
    visa
    mastercard
    amex
    تحويل بنكي

    Product Description:

    • Betmiga is a medicine containing the active substance mirabegron.
    • It is available as prolonged-release tablets (25 mg, 50 mg).
    • Prolonged-release’ means that mirabegron is released slowly from the tablet over a few hours.
    • etmiga is used in adults with overactive bladder syndrome.

    It is used to treat certain symptoms of the condition:

    • urgency (sudden urge to urinate), increased urinary frequency (the need to urinate frequently) and urge incontinence (involuntary leakage of urine from the bladder when a sudden strong need to urinate is felt).
    • The medicine can only be obtained with a prescription.

    How To use:

    • The recommended dose of Betmiga is 50 mg once a day.
    • In patients who have reduced kidney or liver function the doctor may need to prescribe a lower dose or avoid the use of Betmiga, especially in patients taking certain other medicines.

    Warnings And Precautions:

    Do not take BETMIGA if you have an allergy to:

    • Any medicine containing mirabegron

    Some of the symptoms of an allergic reaction may include:

    • Shortness of breath.
    • Wheezing or difficulty breathing.
    • Swelling of the face, lips, tongue or other parts of the body.
    • Rash, itching or hives on the skin.

    Do not take BETMIGA:

    • if you have very high blood pressure (systolic greater than or equal to 180mmhg and /or diastolic greater than or equal to 110mmhg).
    • If you are not sure whether you should start taking this medicine, talk to your doctor.
    • Before you start to take it
    • Tell your doctor if you have allergies to any other medicines, foods, preservatives or dyes.
    • Tell your doctor if you have or have had any of the following medical conditions:
    • Kidney problems
    • Liver problems
    • High blood pressure
    • Heart disorders, including an irregular heartbeat, an abnormal electrical signal in the heart that can cause an irregular heart rhythm called "prolongation of the QT interval", or if you are taking any medicine known to cause irregular heart rhythm (see 'Taking other medicines')
    • Trouble emptying your bladder or you have a weak urine stream
    • Tell your doctor if you are pregnant or plan to become pregnant or are breast-feeding. Your doctor can discuss with you the risks and benefits involved.

    Ingredients:

    • Betmiga 25 mg prolonged-release tablets
    • Betmiga 50 mg prolonged-release tablets
    Reviews and Customer opinions
    Leave a comment

    0.0

    Based On (0) Reviews
    Excellent
    0 Review
    Very good
    0 Review
    Good
    0 Review
    Average
    0 Review
    Bad
    0 Review
    • Categories |
    Reviews and Customer opinions
    Leave a comment

    0.0

    Based On (0) Reviews
    Excellent
    0 Review
    Very good
    0 Review
    Good
    0 Review
    Average
    0 Review
    Bad
    0 Review
    Enter the product review

    Leave a comment

    Number remaining :

    250

    Upload

    Maximum number of images is 3

    Redeem your points for rewards
    have Points
    More